Announcements and Notices - [Inside Information / Other - Trading Update]

TOT Biopharm International Company Limited operates biopharmaceutical company. The Company focuses on development and commercialisation of tumor drugs and therapies. TOT Biopharm International serves clients in China.

Certain Unaudited Financial Information For The Nine Months Ended 30 September 2025

Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]

Supplemental Announcement In Relation To Change
Of Directors, Chief Executive Officer, Authorised
Representative And Composition Of Board Committee

Announcements and Notices - [List of Directors and their Role and Function]

List Of Directors And Their Roles And Functions

Change Of Directors, Chief Executive Officer,
Authorised Representative And Composition Of
Board Committee

Financial Statements/ESG Information - [Interim/Half-Year Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

TOT Biopharm International (1875 HK)

Certain Unaudited Financial Information For The Nine Months Ended 30 September 2025

Supplemental Announcement In Relation To Change Of Directors, Chief Executive Officer, Authorised Representative And Composition Of Board Committee

List Of Directors And Their Roles And Functions

Change Of Directors, Chief Executive Officer, Authorised Representative And Composition Of Board Committee

Interim Report 2025

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)